Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.37−0.01 (-0.72%)
Close on Nov 17, 2026Market cap $103.10MP/E –Yield –
Health Catalyst cash
Cash and short-term investments held at the end of each period.
Health Catalyst's cash was $103.44M at Jun 30, 2026. For fiscal 2025 it was $95.73M, down 75.6% from the year before. The highest annual figure on record is $444.98M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.73M | -75.6% |
| FY2024 | Dec 31, 2024 | $392.00M | +23.4% |
| FY2023 | Dec 31, 2023 | $317.73M | -12.6% |
| FY2022 | Dec 31, 2022 | $363.49M | -18.3% |
| FY2021 | Dec 31, 2021 | $444.98M | +64.3% |
| FY2020 | Dec 31, 2020 | $270.87M | +18.7% |
| FY2019 | Dec 31, 2019 | $228.28M | +587.7% |
| FY2018 | Dec 31, 2018 | $33.19M | +44.5% |
| FY2017 | Dec 31, 2017 | $22.98M | +83.4% |
| FY2016 | Dec 31, 2016 | $12.53M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $103.44M | +6.3% |
| Q1 FY2026 | Mar 31, 2026 | $108.82M | -68.2% |
| Q4 FY2025 | Dec 31, 2025 | $95.73M | -75.6% |
| Q3 FY2025 | Sep 30, 2025 | $91.54M | -76.4% |
| Q2 FY2025 | Jun 30, 2025 | $97.34M | -68.4% |
| Q1 FY2025 | Mar 31, 2025 | $341.97M | +4.3% |
| Q4 FY2024 | Dec 31, 2024 | $392.00M | +23.4% |
| Q3 FY2024 | Sep 30, 2024 | $387.26M | +11.4% |
| Q2 FY2024 | Jun 30, 2024 | $308.26M | -10.3% |
| Q1 FY2024 | Mar 31, 2024 | $327.79M | -8.2% |
| Q4 FY2023 | Dec 31, 2023 | $317.73M | -12.6% |
| Q3 FY2023 | Sep 30, 2023 | $347.70M | -8.5% |
| Q2 FY2023 | Jun 30, 2023 | $343.83M | -14.8% |
| Q1 FY2023 | Mar 31, 2023 | $356.93M | -16.1% |
| Q4 FY2022 | Dec 31, 2022 | $363.49M | -18.3% |
| Q3 FY2022 | Sep 30, 2022 | $380.14M | -16.5% |
| Q2 FY2022 | Jun 30, 2022 | $403.35M | +53.5% |
| Q1 FY2022 | Mar 31, 2022 | $425.42M | +59.7% |
| Q4 FY2021 | Dec 31, 2021 | $444.98M | +64.3% |
| Q3 FY2021 | Sep 30, 2021 | $455.19M | +65.4% |
| Q2 FY2021 | Jun 30, 2021 | $262.76M | -25.6% |
| Q1 FY2021 | Mar 31, 2021 | $266.43M | +30.2% |
| Q4 FY2020 | Dec 31, 2020 | $270.87M | +18.7% |
| Q3 FY2020 | Sep 30, 2020 | $275.14M | +14.0% |
| Q2 FY2020 | Jun 30, 2020 | $353.12M | +553.0% |
| Q1 FY2020 | Mar 31, 2020 | $204.56M | +535.1% |
| Q4 FY2019 | Dec 31, 2019 | $228.28M | +587.7% |
| Q3 FY2019 | Sep 30, 2019 | $241.42M | +759.0% |
| Q2 FY2019 | Jun 30, 2019 | $54.08M | +84.6% |
| Q1 FY2019 | Mar 31, 2019 | $32.21M | +40.2% |
| Q4 FY2018 | Dec 31, 2018 | $33.19M | +164.9% |
| Q3 FY2018 | Sep 30, 2018 | $28.10M | – |
| Q2 FY2018 | Jun 30, 2018 | $29.30M | – |
| Q4 FY2017 | Dec 31, 2017 | $22.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.53M | – |
See a number that looks wrong?